Evidence map›Paper›PMID 29365279›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.

Paul J Collini, Martin A Bewley, Mohamed Mohasin, Helen M Marriott, Robert F Miller, Anna-Maria Geretti, Apostolos Beloukas, Athanasios Papadimitropoulos, Robert C Read, Mahdad Noursadeghi and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  13. Article
  14. Intracellular survival ofFrontiers in immunology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Paul J Collini1 The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom.ORCID 0000-0001-6696-6826
Martin A Bewley1 The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom.
Mohamed Mohasin1 The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom.
Helen M Marriott1 The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom.
Robert F Miller3 Research Department of Infection and Population Health, Institute of Epidemiology & Health Care, Faculty of Population Health Sciences, and.
Anna-Maria Geretti4 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Apostolos Beloukas4 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Athanasios Papadimitropoulos4 Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Robert C Read5 Academic Unit of Clinical and Experimental Sciences, University of Southampton and National Institute for Health Research Southampton Biomedical Research Centre, Southampton, United Kingdom; and.
Mahdad Noursadeghi6 Division of Infection & Immunity, Faculty of Medical Sciences, University College London, London, United Kingdom.
David H Dockrell1 The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Sheffield, United Kingdom.
University of Liverpool · GBUniversity of Sheffield · GBSheffield Teaching Hospitals NHS Foundation Trust · GBInstitute of Epidemiology, Disease Control and Research · BDNational Institute for Health Research · GBUniversity College London · GB

Funding

Department of HealthMedical Research Council G0901963Medical Research Council MR/K015710/1Medical Research Council MR/N013204/1Medical Research Council MR/N026993/1Medical Research Council MR/N02995X/1Medical Research Council MRNO2995X/1
6 · The paper itself

Abstract

rationalePeople living with HIV are at significantly increased risk of invasive pneumococcal disease, despite long-term antiretroviral therapy (ART). The mechanism explaining this observation remains undefined.

objectivesTo determine if apoptosis-associated microbicidal mechanisms, required to clear intracellular pneumococci that survive initial phagolysosomal killing, are perturbed.

methodsAlveolar macrophages (AM) were obtained by BAL from healthy donors or HIV-1-seropositive donors on long-term ART with undetectable plasma viral load. Monocyte-derived macrophages (MDM) were obtained from healthy donors and infected with HIV-1 MEASUREMENTS AND MAIN

resultsHIV-1

conclusionsDespite ART, HIV-1, via gp120, drives persisting innate immune defects in AM microbicidal mechanisms, enhancing susceptibility to pneumococcal disease.

Indexed as

AdultAnti-Retroviral AgentsDisease ResistanceFemaleHIV Envelope Protein gp120HIV InfectionsHumansLung DiseasesMacrophages, AlveolarMaleMiddle AgedPneumococcal InfectionsAnti-Retroviral AgentsHIV Envelope Protein gp120alveolar macrophagegp120HIVStreptococcus pneumoniae

Identifiers

PMID29365279
PMCPMC6006400
OpenAlexW2783545767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.